相关实验视频

Updated: Jun 2, 2025

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

基于结构的虚拟查和药物设计开发莱什曼杀伤性金胺

Gerliny Bezerra de Oliveira¹, Érick Caique Santos Costa², Zenaide Severina do Monte¹

¹Department of Pharmaceutical Sciences, Postgraduate Program in Pharmaceutical Sciences, Federal University of Pernambuco/UFPE, Recife, Brazil.

Chemistry & biodiversity

|January 15, 2025

概括

研究人员设计了新胺化合物来对抗被忽视的寄生虫病莱什曼病. 一些合成的化合物对莱什马尼亚寄生虫表现出有前途的活性,提供了潜在的新疗法.

科学领域:

药用化学医学化学
寄生虫学的寄生虫学
药物发现药物发现药物发现

背景情况:

莱什曼病是一种被忽视的热带疾病,由于毒性和耐药性,治疗选择有限.
开发新的抗莱什曼病剂对于解决这种疾病的全球负担至关重要.

研究的目的:

设计和合成新型胺衍生物作为潜在的抗莱什曼药物.
为了评估这些化合物对莱什马尼亚寄生虫的疗效,使用试氨酸还原酶作为分子标.

主要方法:

对胺基化合物进行虚拟选,以检测试氨酸还原酶的活性位点.
精选的皮里米丁衍生物的化学合成 (Pyr 1-12).
在体外测试合成的化合物对莱什曼亚马逊菌 (Leishmania amazonensis promastigotes和amastigotes) 的试验.

主要成果:

虚拟选发现了皮里米丁与松减少酶的有利结合亲缘关系.
四种合成的胺衍生物 (Pyr 1-9) 显示出对促生虫的活性 (IC50:11.2391.5μM).
三种衍生品对阿马斯蒂哥特表现出适度的活性 (IC50: 81.29153.21 μM).
优化化合物Pyr 10和Pyr 11表现出良好的抗前列腺炎活性 (IC50:11.38±9.7和20.01±13.55μM),选择性得到改善.

结论:

这项研究成功设计和合成了具有抗莱什曼尼活性的新型胺化合物.
胺衍生物向三甲减少酶显示出开发新莱什曼病治疗的潜力.
需要进一步优化,以开发有效的amastigote向剂.

关键词:

抗莱什曼药物皮里米丁衍生物基于结构的药物设计基于结构的虚拟查西减少酶

更多相关视频

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

Published on: December 30, 2012

Development of Leishmania Species Strains with Constitutive Expression of eGFP

Development of Leishmania Species Strains with Constitutive Expression of eGFP

Published on: April 21, 2023

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...